Spots Global Cancer Trial Database for Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects
Official Title: Assessment of Safety, Tolerability and Pharmacokinetics of Single Doses of Oral Dexanabinol in Healthy Subjects
Study ID: NCT02054754
Study Description
Brief Summary: The purpose of this study is to test the safety and observe the pharmacokinetics (distribution and elimination of the drug) of the compound dexanabinol (ETS2101) in healthy male subjects following a single oral dose.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
Quotient Clinical, Nottingham, Nottinghamshire, United Kingdom
Contact Details
Name: Philip Evans, MD
Affiliation: Quotient Clinical
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
